Effects of testosterone on sexual function in men: results of a meta‐analysis

Clinical Endocrinology - Tập 63 Số 4 - Trang 381-394 - 2005
Andrea M. Isidori1, Elisa Giannetta1, Daniele Gianfrilli1, Emanuela A. Greco1, Vincenzo Bonifacio1, Antônio Aversa1, Andrea Fabbri2, Andrea Lenzi3
1Cattedra di Andrologia, Università‘La Sapienza’, Rome,
2Cattedra di Endocrinologia, Dipartimento di Medicina Interna, Università Tor‐Vergata, Rome and
3Cattedra di Endocrinologia, Dipartimento di Fisiopatologia Medica, Università‘La Sapienza’, Rome, Italy

Tóm tắt

Summary

Objectives  The role of androgen decline in the sexual activity of adult males is controversial. To clarify whether sexual function would benefit from testosterone (T) treatment in men with partially or severely reduced serum T levels, we conducted a systematic review and meta‐analysis of placebo‐controlled studies published in the past 30 years. The aim of this study was to assess and compare the effects of T on the different domains of sexual life.

Data source  A comprehensive search of all published randomized clinical trials was performed in MEDLINE, the Cochrane Library, EMBASE and Current Contents databases.

Review methods  Guided by prespecified criteria, software‐assisted data abstraction and quality assessed by two independent reviewers, a total of 17 randomized placebo‐controlled trials were found to be eligible. For each domain of sexual function we calculated the standardized mean difference relative to T and reported the results of pooled estimates of T treatment using the random effect model of meta‐analysis. Heterogeneity, reproducibility and consistency of the findings across studies were explored using sensitivity and meta‐regression analysis.

Results  Overall, 656 subjects were evaluated: 284 were randomized to T, 284 to placebo (P) and 88 treated in cross‐over. The median study length was 3 months (range 1–36 months). Our meta‐analysis showed that in men with an average T level at baseline below 12 nmol/l, T treatment moderately improved the number of nocturnal erections, sexual thoughts and motivation, number of successful intercourses, scores of erectile function and overall sexual satisfaction, whereas T had no effect on erectile function in eugonadal men compared to placebo. Heterogeneity was explored by grouping studies according to the characteristics of the study population. A cut‐off value of 10 nmol/l for the mean T of the study population failed to predict the effect of treatment, whereas the presence of risk factors for vasculogenic erectile dysfunction (ED), comorbidities and shorter evaluation periods were associated with greater treatment effects in the studies performed in hypogonadal, but not in eugonadal, men. Meta‐regression analysis showed that the effects of T on erectile function, but not libido, were inversely related to the mean baseline T concentration. The meta‐analysis of available studies indicates that T treatment might be useful for improving vasculogenic ED in selected subjects with low or low‐normal T levels. The evidence for a beneficial effect of T treatment on erectile function should be tempered with the caveats that the effect tends to decline over time, is progressively smaller with increasing baseline T levels, and long‐term safety data are not available. The present meta‐analysis highlights the need, and pitfalls, for large‐scale, long‐term, randomized controlled trials to formally investigate the efficacy of T replacement in symptomatic middle‐aged and elderly men with reduced T levels and ED.

Từ khóa


Tài liệu tham khảo

10.1016/S0025-7125(16)30611-3

10.1016/S0022-5347(17)34871-1

10.1093/humupd/3.5.455

10.1016/j.eururo.2004.01.005

10.1210/jcem-71-4-963

10.1210/jcem-73-5-1016

10.1046/j.1365-2265.1997.2611108.x

10.1016/S0022-5347(05)67788-9

10.1210/jcem.87.2.8201

Spark R.F., 1980, Impotence is not always psychogenic. Newer insights into hypothalamic–pituitary–gonadal dysfunction, Journal of the American Medical Association, 243, 750, 10.1001/jama.1980.03300340026014

Slag M.F., 1983, Impotence in medical clinic outpatients, Journal of the American Medical Association, 249, 1736, 10.1001/jama.1983.03330370046029

10.1016/S0022-5347(17)49454-7

10.1210/jc.80.12.3546

10.1016/S0022-5347(01)65861-0

10.1016/S0022-5347(05)67363-6

10.1210/jcem-48-6-955

10.1111/j.1365-2265.1981.tb00364.x

10.1007/BF01541595

10.1210/jcem-57-3-557

10.1007/BF01542116

10.1016/S0015-0282(16)49529-4

10.1007/BF01541548

10.1210/jc.83.1.33

10.4088/JCP.v62n0602

10.1210/jc.2002-021058

10.1007/BF01541414

10.1192/bjp.145.2.146

10.1210/jc.75.6.1503

10.1046/j.1464-410X.1996.86316.x

10.1023/A:1024518730222

10.1210/jc.84.8.2647

10.1016/j.urology.2003.11.009

10.1016/j.rmed.2004.02.015

10.1210/endo.136.4.7534702

10.1002/j.1939-4640.1996.tb01847.x

10.1210/en.2003-1699

10.1016/S0140-6736(03)14596-5

10.1056/NEJMp038207

Liverman C.T., 2004, Testosterone and Aging: Clinical Research Directions

10.1016/0306-4530(93)90066-T

10.1007/PL00007086

10.1080/tam.6.1.1.7

10.1080/tam.6.2.86.93

10.1080/tam.6.2.94.99

10.1038/sj.ijir.3900981

Liu P.Y., 2002, A double‐blind, placebo‐controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age‐related androgen deficiency, Journal of Clinical Endocrinology and Metabolism, 87, 3125, 10.1210/jcem.87.7.8630

10.1016/0022-3999(80)90017-3

Vogel W., 1985, A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men, Journal of Clinical Psychiatry, 46, 6

10.1007/BF03348281

10.1046/j.1365-2265.2003.01764.x

10.1097/01.ju.0000132389.97804.d7

10.1177/070674370204700607

Sutton A.J., 2000, Methods for Meta‐analysis in Medical Research

Hedges L.V., 1985, Statistical Methods for Meta‐analysis.

10.1525/ae.2004.31.4.475

10.1037/1082-989X.3.4.486

10.1136/bmj.327.7414.557

10.1210/jcem-65-6-1118

10.1016/0895-4356(91)90028-8

10.1038/sj.ijir.3900446

10.1007/BF01541434

10.1210/jcem-57-1-71

10.1210/jc.74.6.1221

10.1016/S0002-9343(01)00663-5

10.1016/0031-9384(78)90033-1

10.1093/geronj/37.3.288

10.1210/jcem-63-6-1418

10.1097/00006842-198805000-00008

10.1210/jcem-67-5-867

10.1038/sj.ijir.3900832

10.1111/j.1365-2265.2004.02108.x

10.1007/BF01541711

10.1210/jc.84.10.3673

10.1210/jcem.85.5.6572

10.1073/pnas.94.14.7537

10.1002/j.1939-4640.1997.tb01887.x

10.1016/0018-506X(90)90020-X

10.1677/joe.0.1700395

10.1016/0306-4530(92)90023-Z

10.1016/0149-7634(94)00060-E

Hajjar R.R., 1997, Outcomes of long‐term testosterone replacement in older hypogonadal males: a retrospective analysis, Journal of Clinical Endocrinology and Metabolism, 82, 3793, 10.1210/jcem.82.11.4387

10.1016/S0015-0282(16)55938-X

10.1210/jc.79.2.561

10.1111/j.1365-2265.1985.tb01113.x

10.1210/jc.2003-031354

10.1016/S0022-5347(01)66141-X

10.1016/S0022-5347(01)65062-6

10.1210/jc.85.8.2839

10.1210/jcem-70-3-792

10.1016/S0300-595X(82)80003-0

10.1046/j.1365-2265.2000.01118.x

10.1210/jc.86.10.4611